Navigation Links
Mylan Appoints Adele Gulfo as EVP, Global Collaboration and Strategic Operations
Date:1/8/2014

PITTSBURGH, Jan. 8, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced the appointment of Adele Gulfo as executive vice president, Global Collaboration and Strategic Operations. Gulfo will serve as a member of Mylan's executive leadership team.

Prior to joining Mylan, Gulfo served as regional president of Latin America in Pfizer's Emerging Markets Business Unit. In this capacity, she led a team of over 4,000 colleagues operating across more than 23 countries. In 2012, under her leadership, the Latin American business achieved more than $3 billion in revenue, making it the largest revenue generator within the Business Unit. Previously, Gulfo served as president and general manager of Pfizer's U.S. Primary Care Business Unit, which included the Managed Markets (Corporate and Government Customer) organization for all of Pfizer's Biopharmaceutical Business Units. In 2011, Pfizer's U.S. Primary Care business generated $13 billion in revenue under her leadership. Earlier in her career at Pfizer, Gulfo was instrumental in the launch of LIPITOR®, which became the world's most successful medicine in terms of sales, and was recognized for developing medical and public education campaigns that helped to establish the significance of lowering cholesterol in preventing and managing heart disease.

Mylan CEO Heather Bresch commented, "Adele's rich and diverse experience in the pharmaceutical industry will bring significant strategic value and leadership to Mylan in numerous areas. For instance, we believe Adele's expertise will support many of our key growth drivers, including our expansion in Latin America, the development and expansion of our global Specialty franchise, and the development of global commercial strategies to max
'/>"/>

SOURCE Mylan Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Presentation Schedules, Stock Movements, Agreements, and New Appointments - Research Report on Celgene, Merck, Bristol-Myers, Valeant, and Mylan
2. Mylan to Present at the J.P. Morgan 32nd Annual Healthcare Conference
3. Mylan to Present at the Goldman Sachs Healthcare CEOs Unscripted: A View from the Top Conference
4. Rakesh Bamzai Joins Mylan as President, India Commercial and Emerging Markets
5. Mylan Announces Acquisition of Rights to Novel LAMA Respiratory Compound from Pfizer
6. Mylan Launches Cabergoline Tablets
7. Mylan Completes Acquisition of Agila to Create Leading Global Injectables Platform
8. Elton John AIDS Foundation and Mylan Give $1 Million to Nigeria for the Elimination of Mother-to-Child Transmission of HIV
9. Mylan Announces Pricing of $2.0 Billion of Senior Notes
10. Mylan Applauds New Federal Legislation to Increase Anaphylaxis Preparedness in Schools
11. Mylan to Present at the 2013 Credit Suisse Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... March 27, 2015 As of February, ... incontinence devices for women. "Shipping thousands ... gratifying part is the hundreds of letters, emails ... lives have been positively impacted by our technology," ... InControl recently released Apex, an over-the-counter ...
(Date:3/27/2015)... Mass. , March 27, 2015 /PRNewswire/ ... and privately-held MirImmune LLC, today announced that ... agreement to RXi,s novel and proprietary sd-rxRNA® ... cancer immunotherapies. The collaboration has the potential ... patient friendly cancer treatments that could be ...
(Date:3/27/2015)...  Delcath Systems, Inc. (NASDAQ: DCTH ), ... on oncology with an emphasis on the treatment ... reporting of data from a single -center experience ... the Delcath Hepatic Delivery System (Melphalan/HDS) and other ... of Surgical Oncology (SSO) Annual Meeting 2015.  The ...
Breaking Medicine Technology:InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5
... 9 Avinger, Inc., a medical device company ... combat peripheral artery disease, announces the enrollment of ... OcclusioN CrossiNg with thE WildCat CatheTer) clinical trial. ... study intended to evaluate the Wildcat Catheter,s ability ...
... (Nasdaq: PCYC ), a biopharmaceutical company focused ... the treatment of cancer and mediated diseases, today announced ... fiscal quarter and fiscal year ended June 30, 2010 ... 2010.  The company will conduct a conference call and ...
Cached Medicine Technology:First Patient Enrolled in 'CONNECT' Clinical Trial 2Pharmacyclics Announces Date of Fiscal Year End 2010 Financial Results and Conference Call and Presentation at Stifel Nicolaus Healthcare Conference 2
(Date:3/29/2015)... Aliso Viejo, California (PRWEB) March 29, 2015 ... have revealed a new transition from Pixel Film Studios, ... 12 sports transitions made exclusively for Final Cut Pro ... “We’ve given our users the tools needed to effortlessly ... Film Studios introduces TranSports, a new and uniquely styled ...
(Date:3/29/2015)... 2015 “Health is an endo thing, ... learn more about the cannabinoid system … we learn ... Publius’ Go Endo-Cannabinoid Update ~ new on the ... celebrated. Publius, of The Cannabis Papers: A citizen’s guide ... Health (PubMed) cannabinoid system (CS) articles discussing: cannabinoids in ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Coffee could not ... help protect you from gum disease, researchers have found. , ... gum disease. , Coffee contains antioxidants. Antioxidants fight gum disease. ... question researchers at Boston Univ. Henry M. Goldman School of ... the August 2014 issue of the Journal of Periodontology. , ...
(Date:3/28/2015)... "Necrorun" was featured on NewsWatch as part of its ... and coolest applications on the market for iOS, Android, ... technology expert, conducted the app review and shared with ... with knights, nature, and peasants. , The first ... Eurogamer. The popularity of these games grew over the ...
(Date:3/28/2015)... 2015 With more than 4,500 ... of osteoporosis, osteoarthritis and musculoskeletal diseases gathered here ... be the first time in the 17-year history ... the hot-button topic is an emerging non-pharmaceutical protocol ... scientific principles of Wolff’s law, osteogenic loading at ...
Breaking Medicine News(10 mins):Health News:Introducing TranSports for Final Cut Pro X Users from Pixel Film Studios 2Health News:March Homeostasis: Publius’ Go Endo-Cannabinoid Update ~ New on the Bryan William Brickner Blog 2Health News:New Research Impliments Coffee May Help Fight Gum Disease and Increasing Benefits With Tylers Coffee 2Health News:A Grim Endless Runner Game Was Featured on NewsWatch Television on January 30, 2015 2Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2
... ... for pets and their owners, without a safety system in place.,Pets Guardian Emergency Notification ... or other unforeseen event., , ... (PRWEB) July 2, 2010 -- With vacation time here and the economic ...
... Parents ... that their child has a healthy diet, particularly those from wealthier families. Yet, in describing ... or cutting out snacks, junk food and takeaways. , ... (PRWEB) July 4, 2010 -- According to a recent survey, ...
... ... HealthCare Professionals (IAHCP) welcomes esteemed psychiatrist Dr. Lyubov Gorelik into the pages thier exclusive ... New York State as a leader in psychiatry, and will be featured alongside other ... ...
... , ... , and skin care brand, Bellaboo, today released its short documentary clip on teen self esteem ... esteem. , ... One Girl At A Time is giving a voice to the number one issue ...
... ... 2020 America will be in the midst of an allergy and asthma crisis. , ... Phoenix, AZ (Vocus) July 2, 2010 -- DrFinders ... indicates that by the year 2020 there will be such a severe shortage of Allergists that ...
... All ... , ... 2, 2010 -- There’s growing consumer awareness and concern in the U.S. and abroad about ... (July 2010), European food and beverage manufacturers will be required to include a strong warning ...
Cached Medicine News:Health News:Pets Guardian Provides A Pet Safety System, Ensuring Pets Will Be Cared For In Case of a Personal Emergency 2Health News:Pets Guardian Provides A Pet Safety System, Ensuring Pets Will Be Cared For In Case of a Personal Emergency 3Health News:Parents Overestimate Children's Diets as Healthy 2Health News:Parents Overestimate Children's Diets as Healthy 3Health News:Parents Overestimate Children's Diets as Healthy 4Health News:Renowned Psychiatrist, Lyubov Y Gorelik, M.D., is selected to represent New York in The Leading Physicians of the World 2Health News:Bellaboo Releases One Girl At A Time Documentary 2Health News:DrFinders Cites a Study Indicating that by the Year 2020 America will be in the Midst of an Allergy and Asthma Crisis 2Health News:Surf Sweets Among Few Candy Offerings Free of Synthetic Dyes Despite Growing Consumer Concern Over Affect on Children 2Health News:Surf Sweets Among Few Candy Offerings Free of Synthetic Dyes Despite Growing Consumer Concern Over Affect on Children 3Health News:Surf Sweets Among Few Candy Offerings Free of Synthetic Dyes Despite Growing Consumer Concern Over Affect on Children 4
Offers the dual convenience of resecting tissue while simultaneously evacuating through a suction channel in the instrument....
Smith & Nephew ACUFEX scissors are constructed without pins for maximum strength, dependability, durability, and safety.,A wide range of tips and angles enable the surgeon to effectively dissect any ...
The most traditional style of instrument, a classical punch shape with the parrot beak upper jaw to aid in the capture of tissue....
This family of punches offers the best of both worlds the lowest profile and the largest bite, facilitating end-on and lateral cutting the most versatile instrument available....
Medicine Products: